Timothy Goodnow Buys 17,225 Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) CEO Timothy Goodnow purchased 17,225 shares of the firm’s stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average price of $5.79 per share, for a total transaction of $99,732.75. Following the purchase, the chief executive officer owned 651,243 shares in the company, valued at $3,770,696.97. The trade was a 2.72% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link.

Senseonics Holdings, Inc. Common Stock Price Performance

Senseonics Holdings, Inc. Common Stock stock opened at $6.49 on Wednesday. The company has a current ratio of 4.83, a quick ratio of 4.55 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $271.09 million, a price-to-earnings ratio of -3.84 and a beta of 0.90. Senseonics Holdings, Inc. Common Stock has a twelve month low of $5.25 and a twelve month high of $15.74.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in SENS. GSK plc bought a new position in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter worth approximately $60,000. Townsend Asset Management Corp NC ADV bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at approximately $60,000. Sanctuary Advisors LLC bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at approximately $71,000. Captrust Financial Advisors acquired a new stake in Senseonics Holdings, Inc. Common Stock during the fourth quarter worth approximately $77,000. Finally, Jefferies Financial Group Inc. acquired a new stake in Senseonics Holdings, Inc. Common Stock during the fourth quarter worth approximately $82,000. Institutional investors and hedge funds own 12.36% of the company’s stock.

Wall Street Analysts Forecast Growth

SENS has been the subject of several research reports. Stifel Nicolaus set a $9.00 price target on Senseonics Holdings, Inc. Common Stock in a report on Tuesday, March 3rd. TD Cowen reaffirmed a “buy” rating on shares of Senseonics Holdings, Inc. Common Stock in a report on Thursday, January 8th. Finally, Weiss Ratings began coverage on Senseonics Holdings, Inc. Common Stock in a research report on Tuesday, February 17th. They set a “sell (d-)” rating on the stock. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $22.70.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.